Type 1 Diabetes in Focus: Optimizing Outcomes with Early Intervention : Episode 3

Advancing Early Detection: Autoimmune Screening in Type 1 Diabetes

April 11, 2025

Opinion

Video

A panelist discusses how autoimmune screening through detection of diabetes-specific autoantibodies serves as a critical tool for identifying pre-symptomatic type 1 diabetes (T1D), enabling earlier intervention before significant beta cell loss occurs and potentially changing the disease trajectory through timely management strategies.

EP: 1.Type 1 Diabetes: Understanding Disease Progression and Beta Cell Function

EP: 2.C-Peptide and Early Type 1 Diabetes Detection

Now Viewing

EP: 3.Advancing Early Detection: Autoimmune Screening in Type 1 Diabetes

EP: 4.Misdiagnosis of Type 1 Diabetes in Adults: Prevalence, Causes and Consequences

EP: 5.Preserving Beta Cell Function in T1D: Current Strategies and Emerging Therapies

EP: 6.Final Thoughts on Type 1 Diabetes: Innovations, Challenges and the Road Ahead

EP: 7.Type 1 Diabetes in Focus: Optimizing With Early Interventions | Written Recap

Video content above is prompted by the following:

What role does autoimmune screening play in identifying and diagnosing patients with T1D earlier?
In what patients do you recommend screening for autoantibodies?
Do you think autoimmune screening initiatives will gain momentum in the next few years?
How can health care systems and payers improve early screening and diagnosis to better preserve beta cell function?

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!